-+ 0.00%
-+ 0.00%
-+ 0.00%

SUPERNUS PHARMACEUTICALS - FDA GRANTS SEVEN YEARS ORPHAN-DRUG EXCLUSIVITY FOR ONAPGO

Reuters·10/21/2026 23:45:30

Please log in to view news